Inclusion and exclusion criteria
Patients who were diagnosed with localized (cT1-T2) PCa, had RP
operation and were followed up regularly for BCR were included in our
study. Patients diagnosed with metastatic or locally advanced PCa,
patients with positive surgical margins, patients with pathological
lymph node metastasis, patients receiving neo-adjuvant hormonotherapy or
radio-chemotherapy, patients receiving adjuvant therapy after RP,
patients who had nadir PSA above 0.2 ng/dl after RP, patients without
regular follow-up were not included in the study.